MARKET

CSTL

CSTL

Castle
NASDAQ

Real-time Quotes | Nasdaq Last Sale

41.32
+0.27
+0.66%
After Hours: 41.32 0 0.00% 16:00 08/14 EDT
OPEN
41.04
PREV CLOSE
41.05
HIGH
41.54
LOW
40.24
VOLUME
158.76K
TURNOVER
--
52 WEEK HIGH
45.62
52 WEEK LOW
15.26
MARKET CAP
813.27M
P/E (TTM)
124.20
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CSTL stock price target is 49.75 with a high estimate of 52.00 and a low estimate of 47.00.

EPS

CSTL News

More
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 80.95% and 39.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 4d ago
Castle Biosciences Q2 EPS $(0.08) Beats $(0.40) Estimate, Sales $12.70M Up From $10.74M YoY
Castle Biosciences (NASDAQ:CSTL) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.40) by 80 percent. This is a 92.38 percent increase over losses of $(1.05) per share from
Benzinga · 4d ago
Castle Biosciences Announces Second Quarter 2020 Results
Castle Biosciences today announced its financial results for the second quarter and six months ended June 30, 2020.
Business Wire · 4d ago
Castle Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
Castle Biosciences is scheduled to present a company overview at the Canaccord Genuity 40th Annual Growth Conference on Wednesday, August 12, 2020.
Business Wire · 08/05 11:00
Castle Biosciences, Inc. (CSTL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Castle Biosciences, Inc. (CSTL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 08/03 16:31
Castle Biosciences to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
Castle will release its financial results for the second quarter ended June 30, 2020, after the close of market on Monday, August 10, 2020.
Business Wire · 07/27 11:00
The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15)
Benzinga · 07/16 12:31
Castle Biosciences Announces Publication of Clinical Utility, Long-Term Outcomes Data and Meta-Analysis for DecisionDx-UM for Patients with Uveal Melanoma
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the publication of a multicenter, prospective study demonstrating that DecisionDx®-UM t
Business Wire · 07/15 12:42

Industry

Medical Equipment, Supplies & Distribution
-1.00%
Healthcare Equipment & Supplies
-1.06%

Hot Stocks

Symbol
Price
%Change

About CSTL

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company. The Company is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company has two market proprietary products, DecisionDx-Melanoma and DecisionDx-UM, and have two active proprietary products in development DecisionDx-UM and DecisionDx-Melanoma. The Company is developing a treatment plan for certain cancers using clinical and pathology factors. Its lead product, DecisionDx-Melanoma, is a proprietary multi-gene expression profile (GEP), a test that predicts the risk of metastasis or recurrence for patients diagnosed with invasive cutaneous melanoma, a deadly skin cancer.
More

Webull offers kinds of Castle Biosciences Inc stock information, including NASDAQ:CSTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSTL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CSTL stock methods without spending real money on the virtual paper trading platform.